Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study.
J Bradley LaytonJoan FornsLisa J McQuayHeather E DanyshColleen DempseyMary S AnthonyMary Ellen TurnerPublished in: Drug safety (2022)
European Union Post-authorization Study (EU PAS) register number 46331.